Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 6:6:ELIXIR-1649.
doi: 10.12688/f1000research.12342.2. eCollection 2017.

The future of metabolomics in ELIXIR

Affiliations

The future of metabolomics in ELIXIR

Merlijn van Rijswijk et al. F1000Res. .

Abstract

Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of metabolomics in ELIXIR" was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.

Keywords: bioinformatics infrastructure; cloud computing; computational workflows; data standards; databases; metabolomics; multi-omics approaches; training.

PubMed Disclaimer

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Annual count of mentions of the term ‘metabolomics’ (and related terms) in the literature over time, annotated with important milestones in data sharing and standards in metabolomics.
Source: Data from Google Scholar.

Similar articles

  • ELIXIR and Toxicology: a community in development.
    Martens M, Stierum R, Schymanski EL, Evelo CT, Aalizadeh R, Aladjov H, Arturi K, Audouze K, Babica P, Berka K, Bessems J, Blaha L, Bolton EE, Cases M, Damalas DΕ, Dave K, Dilger M, Exner T, Geerke DP, Grafström R, Gray A, Hancock JM, Hollert H, Jeliazkova N, Jennen D, Jourdan F, Kahlem P, Klanova J, Kleinjans J, Kondic T, Kone B, Lynch I, Maran U, Martinez Cuesta S, Ménager H, Neumann S, Nymark P, Oberacher H, Ramirez N, Remy S, Rocca-Serra P, Salek RM, Sallach B, Sansone SA, Sanz F, Sarimveis H, Sarntivijai S, Schulze T, Slobodnik J, Spjuth O, Tedds J, Thomaidis N, Weber RJM, van Westen GJP, Wheelock CE, Williams AJ, Witters H, Zdrazil B, Županič A, Willighagen EL. Martens M, et al. F1000Res. 2023 Oct 3;10:ELIXIR-1129. doi: 10.12688/f1000research.74502.2. eCollection 2021. F1000Res. 2023. PMID: 37842337 Free PMC article.
  • A community proposal to integrate proteomics activities in ELIXIR.
    Vizcaíno JA, Walzer M, Jiménez RC, Bittremieux W, Bouyssié D, Carapito C, Corrales F, Ferro M, Heck AJR, Horvatovich P, Hubalek M, Lane L, Laukens K, Levander F, Lisacek F, Novak P, Palmblad M, Piovesan D, Pühler A, Schwämmle V, Valkenborg D, van Rijswijk M, Vondrasek J, Eisenacher M, Martens L, Kohlbacher O. Vizcaíno JA, et al. F1000Res. 2017 Jun 13;6:ELIXIR-875. doi: 10.12688/f1000research.11751.1. eCollection 2017. F1000Res. 2017. PMID: 28713550 Free PMC article.
  • The de.NBI / ELIXIR-DE training platform - Bioinformatics training in Germany and across Europe within ELIXIR.
    Wibberg D, Batut B, Belmann P, Blom J, Glöckner FO, Grüning B, Hoffmann N, Kleinbölting N, Rahn R, Rey M, Scholz U, Sharan M, Tauch A, Trojahn U, Usadel B, Kohlbacher O. Wibberg D, et al. F1000Res. 2019 Nov 7;8:ELIXIR-1877. doi: 10.12688/f1000research.20244.2. eCollection 2019. F1000Res. 2019. PMID: 33163154 Free PMC article.
  • Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.
    Wolahan SM, Hirt D, Glenn TC. Wolahan SM, et al. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
  • Toward collaborative open data science in metabolomics using Jupyter Notebooks and cloud computing.
    Mendez KM, Pritchard L, Reinke SN, Broadhurst DI. Mendez KM, et al. Metabolomics. 2019 Sep 14;15(10):125. doi: 10.1007/s11306-019-1588-0. Metabolomics. 2019. PMID: 31522294 Free PMC article. Review.

Cited by

  • Metabolic Fingerprint of Chronic Obstructive Lung Diseases: A New Diagnostic Perspective.
    Tsoukalas D, Sarandi E, Thanasoula M, Docea AO, Tsilimidos G, Calina D, Tsatsakis A. Tsoukalas D, et al. Metabolites. 2019 Nov 26;9(12):290. doi: 10.3390/metabo9120290. Metabolites. 2019. PMID: 31779131 Free PMC article.
  • Capillary Electrophoresis-Mass Spectrometry at Trial by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible and Robust Compound Annotation.
    Drouin N, van Mever M, Zhang W, Tobolkina E, Ferre S, Servais AC, Gou MJ, Nyssen L, Fillet M, Lageveen-Kammeijer GSM, Nouta J, Chetwynd AJ, Lynch I, Thorn JA, Meixner J, Lößner C, Taverna M, Liu S, Tran NT, Francois Y, Lechner A, Nehmé R, Al Hamoui Dit Banni G, Nasreddine R, Colas C, Lindner HH, Faserl K, Neusüß C, Nelke M, Lämmerer S, Perrin C, Bich-Muracciole C, Barbas C, Gonzálvez ÁL, Guttman A, Szigeti M, Britz-McKibbin P, Kroezen Z, Shanmuganathan M, Nemes P, Portero EP, Hankemeier T, Codesido S, González-Ruiz V, Rudaz S, Ramautar R. Drouin N, et al. Anal Chem. 2020 Oct 20;92(20):14103-14112. doi: 10.1021/acs.analchem.0c03129. Epub 2020 Oct 1. Anal Chem. 2020. PMID: 32961048 Free PMC article. Clinical Trial.
  • ELIXIR and Toxicology: a community in development.
    Martens M, Stierum R, Schymanski EL, Evelo CT, Aalizadeh R, Aladjov H, Arturi K, Audouze K, Babica P, Berka K, Bessems J, Blaha L, Bolton EE, Cases M, Damalas DΕ, Dave K, Dilger M, Exner T, Geerke DP, Grafström R, Gray A, Hancock JM, Hollert H, Jeliazkova N, Jennen D, Jourdan F, Kahlem P, Klanova J, Kleinjans J, Kondic T, Kone B, Lynch I, Maran U, Martinez Cuesta S, Ménager H, Neumann S, Nymark P, Oberacher H, Ramirez N, Remy S, Rocca-Serra P, Salek RM, Sallach B, Sansone SA, Sanz F, Sarimveis H, Sarntivijai S, Schulze T, Slobodnik J, Spjuth O, Tedds J, Thomaidis N, Weber RJM, van Westen GJP, Wheelock CE, Williams AJ, Witters H, Zdrazil B, Županič A, Willighagen EL. Martens M, et al. F1000Res. 2023 Oct 3;10:ELIXIR-1129. doi: 10.12688/f1000research.74502.2. eCollection 2021. F1000Res. 2023. PMID: 37842337 Free PMC article.
  • Experimental Design and Sample Preparation in Forest Tree Metabolomics.
    Rodrigues AM, Ribeiro-Barros AI, António C. Rodrigues AM, et al. Metabolites. 2019 Nov 22;9(12):285. doi: 10.3390/metabo9120285. Metabolites. 2019. PMID: 31766588 Free PMC article. Review.
  • The ChemicalToolbox: reproducible, user-friendly cheminformatics analysis on the Galaxy platform.
    Bray SA, Lucas X, Kumar A, Grüning BA. Bray SA, et al. J Cheminform. 2020 Jun 1;12(1):40. doi: 10.1186/s13321-020-00442-7. J Cheminform. 2020. PMID: 33431029 Free PMC article.

References

    1. Kell DB, Oliver SG: The metabolome 18 years on: a concept comes of age. Metabolomics. 2016;12(9):148. 10.1007/s11306-016-1108-4 - DOI - PMC - PubMed
    1. Fiehn O, Robertson D, Griffin J, et al. : The metabolomics standards initiative (MSI). Metabolomics. 2007;3(3):175–8. 10.1007/s11306-007-0070-6 - DOI
    1. Sansone SA, Schober D, Atherton HJ, et al. : Metabolomics standards initiative: ontology working group work in progress. Metabolomics. 2007;3(3):249–56. 10.1007/s11306-007-0069-z - DOI
    1. Goodacre R: Water, water, every where, but rarely any drop to drink. Metabolomics. 2014;10(1):5–7. 10.1007/s11306-013-0618-6 - DOI
    1. Lindon JC, Nicholson JK, Holmes E, et al. : Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol. 2005;23(7):833–8. 10.1038/nbt0705-833 - DOI - PubMed

LinkOut - more resources